Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 5 Results

  1. 1
    333820

    Investing in communities: annual review 2011.

    International HIV / AIDS Alliance

    [Hove, United Kingdom], International HIV / AIDS Alliance, 2012 Jun. [19] p.

    Our vision is a world in which people do not die of aids. For us, this means a world in which communities: have brought HIV under control by preventing its transmission; enjoy better health; and can fully exercise their human rights. Our mission is to support community action to prevent HIV infection, meet the challenges of AIDS, and build healthier communities.We take great pride investing in a community-based response that understands what works in a local context, and that is strengthened by learning from a global partnership of national organisations. In 2011 this approach enabled us to reach 2.8 million people.
    Add to my documents.
  2. 2
    312299

    Stop TB Partnership -- annual report 2005.

    World Health Organization [WHO]. Stop TB Partnership

    Geneva, Switzerland, WHO, 2006. [52] p. (WHO/HTM/STB/2006.36)

    During 2005, the Stop TB Partnership continued to work towards the goal of eliminating tuberculosis (TB) as a public health problem and obtaining a world free of TB. Through a dynamic network of international organizations, national governments, donors and nongovernmental organizations that share this goal, the Partnership strengthened its reputation as an effective force in global TB control. The major achievement of the Stop TB Partnership in 2005 was the development of the Global Plan to Stop TB, 2006--2015, a blueprint for TB control over the coming decade. This landmark achievement was the result of intense work by the Partnership's Working Groups and all of its partners, and is underpinned by the new Stop TB Strategy of WHO. The Global Plan and the new Stop TB Strategy were both endorsed by the Coordinating Board (CB) of the Partnership. The CB met twice in 2005, first in Addis Ababa (Ethiopia) and then in Assisi (Italy), and took major decisions on governance, business processes and technical issues. The CB delegations undertook a number of important advocacy missions on behalf of the Stop TB Partnership including Gaborone (Botswana), Ottawa (Canada), Jakarta (Indonesia), Rome (Italy) and Maputo (Mozambique). (excerpt)
    Add to my documents.
  3. 3
    300765

    Global tuberculosis control: surveillance, planning, financing. WHO report 2005.

    World Health Organization [WHO]

    Geneva, Switzerland, WHO, 2005. [255] p. (WHO/HTM/TB/2005.349)

    The goal of this series of annual reports is to chart progress in global TB control and, in particular, to evaluate progress in implementing the DOTS strategy. The first targets set for global TB control were ratified in 1991 by WHO’s World Health Assembly. They are to detect 70% of new smearpositive TB cases, and to successfully treat 85% of these cases. Since these targets were not reached by the end of year 2000 as originally planned, the target year was deferred to 2005.4 In 2000, the United Nations created a new framework for monitoring progress in human development, the MDGs. Among 18 MDG targets, the eighth is to “have halted by 2015 and begun to reverse the incidence of malaria and other major diseases”. Although the objective is expressed in terms of incidence, the MDGs also specify that progress should be measured in terms of the reduction in TB prevalence and deaths. The target for these two indicators, based on a resolution passed at the 2000 Okinawa (Japan) summit of G8 industrialized nations, and now adopted by the Stop TB Partnership, is to halve TB prevalence and death rates (all forms of TB) between 1990 and 2015. All three measures of impact (incidence, prevalence and death rates) have been added to the two traditional measures of DOTS implementation (case detection and treatment success), so that the MDG framework includes five principal indicators of progress in TB control. All five MDG indicators will, from now on, be evaluated by WHO’s Global TB Surveillance, Planning and Financing Project. The focus is on the performance of NTPs in 22 HBCs, and in priority countries in WHO’s six regions. (excerpt)
    Add to my documents.
  4. 4
    177269

    Global tuberculosis control: surveillance, planning, financing. WHO report 2003. [Contrôle mondial de la tuberculose: surveillance, planification, financement. Rapport OMS 2003]

    Blanc L; Bleed D; Dye C; Floyd K; Palmer K

    Geneva, Switzerland, World Health Organization [WHO], Communicable Diseases, 2003. vii, 40 p. (WHO/CDS/TB/2003.316)

    Conclusions: If the current rate of DOTS expansion in maintained, the 70% detection target will not be reached by 2005. If that target is ever to be reached, DOTS programmes must improve case finding within designated DOTS areas, and must expand to new areas. To reach the 85% target for treatment success, cure rates must be improved under DOTS in some countries, especially those in sub-Saharan Africa. Although funding for tuberculosis programmes, and planning for DOTS expansion, both improved during 2002, deficiencies in staff and health infrastructure are likely to hinder progress towards both of the global targets. At present, National Tuberculosis Control Programmes are significantly underestimating the cost of rectifying these deficiencies. (excerpt)
    Add to my documents.
  5. 5
    129532

    TB: WHO report on the tuberculosis epidemic 1997.

    Armstrong S; McDermott R; Klaudt K

    Geneva, Switzerland, World Health Organization [WHO], 1997. 52, [23] p.

    The primary objective of the World Health Organization (WHO) Global Tuberculosis Program is to promote more widespread use of the directly observed treatment (DOTS) strategy. After infectious tuberculosis cases are identified, a health worker watches the patient swallow the medication and the health service monitors progress until patients are cured. When a potent combination of drugs is used for just 6 months, the DOTS management system can cure 85-95% of patients. Other advantages of this strategy include prevention of multidrug-resistant tuberculosis strains, cost-effectiveness (US$1-5 for each disability-adjusted life year saved), protection of the labor force and international travelers, ability to be administered in a community-based primary health care setting, and its positive effect on the survival of tuberculosis patients with AIDS. In 1996, however, only 10% of global tuberculosis patients were treated through the DOTS strategy. This 1997 Annual Report of the WHO Global Tuberculosis Program includes tables on tuberculosis cases and DOTS use in the world's regions, outlines a plan for extending DOTS use, and presents summaries of innovative tuberculosis control programs in Pakistan, India, Bangladesh, Thailand, Indonesia, the Philippines, China, Brazil, Mexico, Russia, Ethiopia, Zaire, and South Africa.
    Add to my documents.